Plain-English translation of NCT01712620 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a medication that blocks certain hormones in your body, can help people with pulmonary arterial hypertension (a rare condition where blood pressure in the lungs becomes dangerously high). Researchers believe this medication may reduce inflammation in blood vessels and improve how far patients can walk and exercise. The study will compare the medication to a placebo (a pill with no active ingredient) to see if it really works.
Pulmonary arterial hypertension is a serious condition where inflammation damages the delicate blood vessels in the lungs, leading to heart failure and poor survival. This medication is already used in advanced cases, but doctors want to see if starting it earlier—before the heart fails—might prevent that damage and help patients live longer, healthier lives.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either or a placebo pill daily. Throughout the study, you will visit the NIH Clinical Center for standard heart exams, exercise tests (like a 6-minute walk), heart ultrasounds, and blood tests to measure inflammation markers. The study will track how far you can walk, how you feel, and whether your condition worsens, helping doctors understand if this medication truly helps people with lung high blood pressure.
AI-generated summary from trial data · Aug 25, 2026 · Not medical advice
United States